Archive - February 2022
NICE recommends GSK’s Zejula for patients with ovarian cancer
Takeda agrees on $2bn deal with Code Bio to expand its gene therapy programmes
Data from first DMT-assisted clinical trial revealed
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Achieving the ‘design one, build many’ paradigm
COVID: How Will People Behave When Self-Isolation Isn’t Mandatory?
What Is Chronic Fatigue Syndrome? Overlooked Condition Shares Symptoms With Long COVID
Dog Ownership Protects Against Disability In Older People: Study